• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

墨西哥女性的生化、超声和人口统计学参数与 IVF/ICSI 治疗卵巢反应的相关性。

Correlation between biochemical, ultrasonographic and demographic parameters with ovarian response to IVF/ICSI treatments in Mexican women.

机构信息

Centro Médico Nacional 20 de Noviembre, Mexico City, Mexico.

出版信息

JBRA Assist Reprod. 2021 Feb 2;25(1):4-9. doi: 10.5935/1518-0557.20200040.

DOI:10.5935/1518-0557.20200040
PMID:32489091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7863092/
Abstract

OBJECTIVE

Ovarian response from a conventional ovarian stimulation protocol is a crucial step in IVF/ICSI treatments. This ovarian response encompasses a wide range of outcomes at the extremes, leading to either excessive responses with the risk of life-threatening conditions like ovarian hyperstimulation syndrome (OHSS), or poor ovarian response (POR) with poor outcomes. This study aims to integrate biochemical, ultrasonographic and demographic parameters into a mathematical formula able to predict ovarian response to stimulation in IVF/ICSI in gonadotropin-releasing hormone (GnRH) antagonist protocols.

METHODS

This retrospective analysis included 147 patients submitted to an ovarian stimulation protocol combining recombinant FSH and gonadotropin-releasing hormone antagonist. All the parameters were correlated with the Spearman Rho and Pearson´s correlation coefficient. Once the data was normalized, we used the multiple linear regression models, checking the results with the progressive discriminating analysis.

RESULTS

We classified the database according to the correlation with the number of oocytes retrieved; the progressive discriminating analysis resulted in the following equation: oocytes retrieved = 2.312-0.130 (FSH) + 0.562 (AFC).

CONCLUSIONS

The incorporation of 2 ovarian reserve parameters into a regression equation enables knowing the number of retrieved oocytes in each patient with 80.5% sensitivity and 55.4% specificity.

摘要

目的

在体外受精/卵胞浆内单精子注射(IVF/ICSI)治疗中,常规卵巢刺激方案的卵巢反应是一个关键步骤。这种卵巢反应在极端情况下涵盖了广泛的结果,导致过度反应,存在危及生命的卵巢过度刺激综合征(OHSS)等风险,或者卵巢反应不良(POR)导致不良结局。本研究旨在将生化、超声和人口统计学参数整合到一个数学公式中,以预测 GnRH 拮抗剂方案中 IVF/ICSI 中卵巢对刺激的反应。

方法

本回顾性分析纳入了 147 名接受重组 FSH 和 GnRH 拮抗剂联合卵巢刺激方案的患者。所有参数均与 Spearman Rho 和 Pearson 相关系数相关。在对数据进行归一化后,我们使用多元线性回归模型,并通过逐步判别分析检查结果。

结果

我们根据与获得的卵母细胞数量的相关性对数据库进行分类;逐步判别分析得出以下方程:获得的卵母细胞数=2.312-0.130(FSH)+0.562(AFC)。

结论

将 2 个卵巢储备参数纳入回归方程,可以以 80.5%的敏感性和 55.4%的特异性预测每位患者获得的卵母细胞数量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ee/7863092/d5a806f999cd/jbra-25-01-0004-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ee/7863092/f4f7784ef612/jbra-25-01-0004-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ee/7863092/f12caebfa5a5/jbra-25-01-0004-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ee/7863092/c9b1043e73d5/jbra-25-01-0004-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ee/7863092/d5a806f999cd/jbra-25-01-0004-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ee/7863092/f4f7784ef612/jbra-25-01-0004-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ee/7863092/f12caebfa5a5/jbra-25-01-0004-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ee/7863092/c9b1043e73d5/jbra-25-01-0004-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ee/7863092/d5a806f999cd/jbra-25-01-0004-g04.jpg

相似文献

1
Correlation between biochemical, ultrasonographic and demographic parameters with ovarian response to IVF/ICSI treatments in Mexican women.墨西哥女性的生化、超声和人口统计学参数与 IVF/ICSI 治疗卵巢反应的相关性。
JBRA Assist Reprod. 2021 Feb 2;25(1):4-9. doi: 10.5935/1518-0557.20200040.
2
[Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].[每个取卵周期的累积活产率:体外受精/卵胞浆内单精子注射临床结局评估]
Zhonghua Fu Chan Ke Za Zhi. 2018 Mar 25;53(3):160-166. doi: 10.3760/cma.j.issn.0529-567X.2018.03.004.
3
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.促性腺激素释放激素(GnRH)拮抗剂方案与GnRH激动剂方案中严重卵巢过度刺激综合征的风险:一项纳入1050个首次体外受精/卵胞浆内单精子注射周期的随机对照试验
Hum Reprod. 2016 Jun;31(6):1253-64. doi: 10.1093/humrep/dew051. Epub 2016 Apr 8.
4
Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.抗缪勒管激素血清采样与起始卵巢刺激之间的时间间隔是否会影响其在 GnRH 拮抗剂的体外受精-胞浆内单精子注射周期中的预测能力?一项回顾性单中心研究。
Fertil Steril. 2013 Aug;100(2):438-44. doi: 10.1016/j.fertnstert.2013.03.031. Epub 2013 Apr 16.
5
GnRH antagonist rescue of a short-protocol IVF/ICSI cycle and GnRH agonist triggering to prevent ovarian hyperstimulation syndrome: two case reports.促性腺激素释放激素拮抗剂挽救短方案体外受精/卵胞浆内单精子注射周期及促性腺激素释放激素激动剂触发以预防卵巢过度刺激综合征:两例报告
Clin Exp Obstet Gynecol. 2017;44(2):279-282.
6
A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.对于有卵巢过度刺激综合征风险且正在接受控制性卵巢刺激的患者,采用促性腺激素释放激素激动剂触发排卵并积极进行黄体期支持。
Taiwan J Obstet Gynecol. 2015 Oct;54(5):583-7. doi: 10.1016/j.tjog.2015.08.012.
7
Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.抗苗勒管激素、促卵泡生成素及窦卵泡计数对接受 GnRH 拮抗剂方案进行体外受精/胚胎移植的女性卵巢刺激结局的预测价值。
Arch Gynecol Obstet. 2014 Dec;290(6):1249-53. doi: 10.1007/s00404-014-3332-3. Epub 2014 Jul 8.
8
[Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].国产高纯度尿促卵泡素对控制性卵巢刺激中体外受精-胚胎移植结局的影响
Zhonghua Fu Chan Ke Za Zhi. 2013 Nov;48(11):838-42.
9
Does an FSH surge at the time of hCG trigger improve IVF/ICSI outcomes? A randomized, double-blinded, placebo-controlled study.在人绒毛膜促性腺激素(hCG)扳机时刻出现促卵泡生成素(FSH)峰是否能改善体外受精/卵胞浆内单精子注射(IVF/ICSI)结局?一项随机、双盲、安慰剂对照研究。
Hum Reprod. 2020 Jun 1;35(6):1411-1420. doi: 10.1093/humrep/deaa087.
10
Controlled ovarian hyperstimulation for poor ovarian responders undergoing in vitro fertilisation/intracytoplasmic sperm injection: a protocol for systematic review and Bayesian network meta-analysis.体外受精/卵胞浆内单精子注射中卵巢反应不良者的控制性卵巢过度刺激:系统评价和贝叶斯网络Meta分析方案
BMJ Open. 2021 Feb 23;11(2):e039122. doi: 10.1136/bmjopen-2020-039122.

引用本文的文献

1
Predicting factors of ovarian responses in infertile women with polycystic ovary syndrome undergoing IVF/ICSI.多囊卵巢综合征不孕女性接受体外受精/卵胞浆内单精子注射时卵巢反应的预测因素
J Assist Reprod Genet. 2025 Mar;42(3):865-874. doi: 10.1007/s10815-024-03386-1. Epub 2025 Jan 14.
2
High ovarian responders have the highest risk of premature progesterone rise.高卵巢反应者有发生孕激素过早升高的最高风险。
JBRA Assist Reprod. 2024 Jun 1;28(2):295-298. doi: 10.5935/1518-0557.20240004.
3
An Individualized Recommendation for Controlled Ovary Stimulation Protocol in Women Who Received the GnRH Agonist Long-Acting Protocol or the GnRH Antagonist Protocol: A Retrospective Cohort Study.

本文引用的文献

1
Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles.个体化起始剂量的卵泡刺激素 delta 可降低总体 OHSS 风险和/或需要额外预防干预的风险:三个刺激周期的累积数据。
Reprod Biomed Online. 2019 Apr;38(4):528-537. doi: 10.1016/j.rbmo.2018.12.032. Epub 2018 Dec 23.
2
Conventional versus minimal ovarian stimulation: an intra-patient comparison of ovarian response in poor-responder women according to Bologna Criteria.常规与微刺激方案:根据博洛尼亚标准对卵巢反应不良患者进行的患者内比较。
Reprod Biomed Online. 2018 Oct;37(4):434-441. doi: 10.1016/j.rbmo.2018.07.007. Epub 2018 Aug 23.
3
基于 GnRH 激动剂长效方案或 GnRH 拮抗剂方案接受控制性卵巢刺激的女性的个体化推荐:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2022 Jul 22;13:899000. doi: 10.3389/fendo.2022.899000. eCollection 2022.
4
Novel insights on premature progesterone elevation: a mini-review.关于孕激素过早升高的新见解:一篇迷你综述。
JBRA Assist Reprod. 2022 Aug 4;26(3):531-537. doi: 10.5935/1518-0557.20210096.
New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation.
基于卵巢卵泡波概念的卵巢刺激新策略:从常规到随机和双重刺激。
Reprod Biomed Online. 2018 Oct;37(4):489-497. doi: 10.1016/j.rbmo.2018.07.006. Epub 2018 Aug 11.
4
Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation.多中心评价 Access AMH 抗缪勒管激素检测在预测窦卵泡数和卵巢对控制性卵巢刺激反应不良中的作用。
Fertil Steril. 2018 Aug;110(3):506-513.e3. doi: 10.1016/j.fertnstert.2018.03.031. Epub 2018 Jun 28.
5
Testing ovarian reserve in pre-menopausal women: why, whom and how?绝经前女性卵巢储备功能检测:为何检测、检测谁以及如何检测?
Maturitas. 2018 Mar;109:112-117. doi: 10.1016/j.maturitas.2017.11.014. Epub 2017 Nov 22.
6
Establishment and validation of a score to predict ovarian response to stimulation in IVF.建立并验证一种评分系统,以预测 IVF 中卵巢对刺激的反应。
Reprod Biomed Online. 2018 Jan;36(1):26-31. doi: 10.1016/j.rbmo.2017.09.011. Epub 2017 Oct 12.
7
Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles.女性年龄、血清抗苗勒管激素水平和卵母细胞数量会影响体外受精/卵胞浆内单精子注射周期中整倍体囊胚的形成率和数量。
Fertil Steril. 2017 Nov;108(5):777-783.e2. doi: 10.1016/j.fertnstert.2017.08.029. Epub 2017 Oct 4.
8
Ovarian reserve testing: a user's guide.卵巢储备测试:用户指南。
Am J Obstet Gynecol. 2017 Aug;217(2):129-140. doi: 10.1016/j.ajog.2017.02.027. Epub 2017 Feb 21.
9
A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles.一项随机对照试验,旨在研究使用预测列线图来选择体外受精/卵胞浆内单精子注射周期中促卵泡激素的起始剂量。
Reprod Biomed Online. 2017 Apr;34(4):429-438. doi: 10.1016/j.rbmo.2017.01.012. Epub 2017 Jan 23.
10
Ovarian stimulation protocols for IVF: is more better than less?体外受精的卵巢刺激方案:多比少好吗?
Reprod Biomed Online. 2017 Apr;34(4):345-353. doi: 10.1016/j.rbmo.2017.01.010. Epub 2017 Jan 24.